Toggle light / dark theme

(Natural News) KFC makes much of its “secret blend of herbs and spices,” but there’s a much simpler reason that people tend to find the flavor of the restaurant’s chicken so striking and find themselves craving more: All KFC chicken is literally marinated in MSG.

MSG, or monosodium glutamate, is an artificial salt designed to activate the “umami” taste receptors on the tongue that give food a full, savory flavor. Unlike naturally occurring glutamate, which is an amino acid found in foods such as anchovies, tomato paste, soy sauce, Worcestershire sauce and parmesan cheese, MSG has been connected with various health problems, with some individuals more sensitive than others.

Some of the dangers of MSG might stem from the fact that it is a highly concentrated form of glutamate, which is not only an amino acid but also a neurotransmitter. Such chemicals are known as excitotoxins, meaning that while they are beneficial in low doses, in high doses they can overstimulate neurons literally to death.

Read more

BMI is coming fast and will replace many devices we have today. Advances we making in deep brain development are huge markers that pushes the BMI needle forward for the day when IoT, Security, and big data analytics is a human brain’s and a secured Quantum Infrastructure and people (not servers sitting somewhere) owns and manages their most private of information. I love calling it the age of people empowerment as well as singularity.


Small study in 16 people suggests technique is safe and might help improve mood, anxiety and wellbeing, while increasing weight.

Deep brain stimulation might alter the brain circuits that drive anorexia nervosa symptoms and help improve patients’ mental and physical health, according to a small study published in The Lancet Psychiatry.

Read more

Bill and Melinda Gates say “the future will surprise the pessimists.”


They discovered childhood mortality is a symptom of other issues

Children’s deaths are often a result of lack of birth control, gender inequality, and poor women’s health. Melinda wrote, “Virtually all advances in society—nutrition, education, access to contraceptives, gender equity, economic growth—show up as gains in the childhood mortality chart, and every gain in this chart shows up in gains for society.”

Bill added, “When women in developing countries space their births by at least three years, their babies are almost twice as likely to reach their first birthday. Over time, the ability of women to use contraceptives and space their pregnancies will become one of the largest contributors in cutting childhood deaths.” In fact, the Gates Foundation reports “no country in the last 50 years has emerged from poverty without expanding access to contraceptives.”

Read more

Contrary to what has long been believed, the role of the sympathetic nervous system in muscle tissue goes far beyond controlling blood flow by contracting or relaxing blood vessels, according to studies conducted at the University of São Paulo (USP) in Brazil.

With support from FAPESP and the collaboration of researchers at Mannheim University and Heidelberg University in Germany, a group of Brazilian researchers led by Isis do Carmo Kettelhut and Luiz Carlos Carvalho Navegantes at the University of São Paulo’s Ribeirão Preto Medical School (FMRP USP) have demonstrated the importance of sympathetic innervation for the growth and maintenance of muscle mass and also for the control of movement.

Kettelhut is a full professor at FMRP -USP’s Biochemistry & Immunology Department. Navegantes is a professor in the same institution’s Physiology Department.

Read more

Orginal press: http://www.prweb.com/releases/2017/02/prweb14062199.htm

Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused on the development of novel biologics for complex regeneration and disease reversion, and SC21 Biotech, (http://www.sc21bio.tech), a biotechnology company focused on translational therapeutic applications of autologous stem cell therapy, have announced a collaboration to focus on novel cellular reprogramming and production approaches for CCR5 Delta32 homozygous cord blood stem cells, for long-term control of HIV via transplantation.

“We are very excited about this collaboration with SC21 Biotech,” said Ira S. Pastor, CEO, Bioquark Inc. “The natural synergy of our cellular reprogramming tools and SC21 Biotech’s translational cell therapy experience, will make for a transformational opportunity in this area of HIV disease control.”

HIV-1 infection afflicts more than 35 million people worldwide. For individuals who have access to antiretroviral therapy, these drugs can effectively suppress, but not cure, HIV-1 infection. The only documented case for an HIV/AIDS cure was a patient with HIV-1 and acute myeloid leukemia who received allogeneic hematopoietic cell transplantation from a graft that carried the HIV-resistant CCR5-Delta32 homozygous mutation. The patient has remained without any evidence of HIV infection for more than 8 years after discontinuation of antiretroviral drug therapy.

However, identifying immune matched adult CCR5- Delta32 homozygous donors for a given patients is not readily feasible in part because the prevalence is in only about 0.8%–1% of individuals of northern European descent and much less in other ethnic groups, as well as the fact that for such transplants with adult cells there needs to be a very close HLA match between donor and patient.

In contrast, cord blood that is CCR5- Delta32 homozygous provides a major advantage in that much less stringent HLA matching is required between donor and patient. However, a technological method to cost effectively and industrially scale the production of such cells has been missing.

“We look forward to working closely with Bioquark Inc. on this exciting initiative,” said Mr. Paul Collier, Managing Director of SC21 Biotech. “The ability to apply Bioquark’s cellular reprogramming tools in order to produce industrial quantities of such precious cell lines will offer a much greater global penetration of this important therapeutic modality for HIV.”

“Bioquark has spent several years studying the evolutionarily perfected ability of bioactive moieties found in ooplasms to turn back biological time and re-set cellular regulatory state” said Dr. Sergei Paylian, Founder, CSO, and President, Bioquark Inc. “This unique initiative is one more step in our broad translation of such natural capabilities to control the progression of human diseases.”

About Bioquark, Inc.

Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.

About SC21 Biotech

SC21 Biotech is a novel a biotechnology company focused on translational therapeutic applications, as well as expedited, experimental access for “no option” patients, to a novel range of regenerative and reparative biomedical products and services, with the goal of reducing human degeneration, suffering, and death.

Don’t be the CIO that sees their own this market as most Healthcare CIO’s will not allowed to stay given they are now a brand liability not to mention all those lawsuits that are coming from lawyers of the patients.


Electronic health record databases proving to be some of the most lucrative stolen data sets in cybercrime underground.

Medical insurance identification, medical profiles, and even complete electronic health record (EHR) databases have attracted the eyes of enterprising black hats, who increasingly see EHR-related documents as some of the hottest commodities peddled in the criminal underground. A new report today shows that complete EHR databases can fetch as much as $500,000 on the Deep Web, and attackers are also making their money off of smaller caches of farmed medical identities, medical insurance ID card information, and personal medical profiles.

The data comes by way of a report from Trend Micro’s TrendLabs Forward-Looking Threat Research (FTR) Team, which took a comprehensive look at how attackers are taking advantage of healthcare organizations’ weaknesses to devastating effect. Cybercriminals always have their eyes open for new profitable revenue streams, and the poor security around increasingly data-rich EHR systems pose a huge opportunity for the bad guys.

Husar, a 38-year-old telecom salesman, had spent most of his life eating the sort of Eastern European fare typical of his native Ukraine: lots of meat, potatoes, salt and saturated fats. DNA Lifestyle Coach suggested his body might appreciate a more Mediterranean diet instead.


Recently, Vitaliy Husar received results from a DNA screening that changed his life. It wasn’t a gene that suggested a high likelihood of cancer or a shocking revelation about his family tree. It was his diet. It was all wrong.

Read more

Nice. My friend Alex Zhavoronkov will appreciate this article.


Feb. 16 (UPI) — Researchers at McGill University in Montreal have found that targeting the internal circadian or biological clock of cancer cells can affect growth.

Most cells in the human body have an internal clock that sets a rhythm for activities of organs depending on the time of day. However, this internal clock in cancer cells does not function at all or malfunctions.

“There were indications suggesting that the malfunctioning clock contributed to rapid tumor growth, but this had never been demonstrated,” Nicolas Cermakian, a professor in the department of psychiatry at McGill University, director of the Laboratory of Molecular Chronobiology at the Douglas Mental Health University Institute and author of the study, said in a press release. “Thanks to the use of a chemical or a thermic treatment, we succeeded in ‘repairing’ these cells’ clock and restoring it to its normal functioning. In these conditions, tumor growth drops nearly in half.”

Nice.


A suite of flexible and biocompatible threads, embedded with sensors and electronics, can be sutured/woven into tissue for in situ measurements of physical and chemical biomarkers.

Real-time monitoring of chronic or surgical wounds for signs of infection or inflammation can drastically improve the health outcomes from these issues. Such monitoring requires that sensors be embedded deep within the tissue. In addition, the acquired information needs to be communicated to the doctor/caregiver so that patient-specific treatments can be optimized. Although recent miniaturization of sensors, as well as the fabrication of smart materials, has allowed the development of the necessary devices (e.g., electrocardiogram electrodes, temperature sensors, pH sensors, and flexible batteries) to continuously monitor a patient’s health status,1–5 there are still several challenges that need to be overcome. Such problems include the mismatch between mechanical and topographical properties of semiconductor-based electronics and biological tissues, as well as flexibility and biocompatibility issues.

When and if that hurdle is overcome, the researchers say that the easily-fabricated stretchy technology could begin to find commercial applications, in devices like rubbery wrist-worn health trackers, deformable tablets and electronic wallpaper that can make huge screens out of entire walls.

“We have created a new technology that is not yet available,” says Wang. “And we have taken it one big step beyond the flexible screens that are about to become commercially available.”

The research was published in the journal ACS Nano.

Read more